Insights

Growth Signals ASKGENE PHARMA has recently advanced development efforts with IND submissions for ASKG915 and strategic hires including a Chief Medical Officer and a VP of Preclinical/Clinical Pharmacology, indicating expanded clinical programs and potential collaboration opportunities.

Strategic Partnerships Existing licensing and development partnerships with AffaMed for retinal disease programs suggest a receptive environment for additional in-Asia collaborations, technology licensing, or co-development ventures.

Funding Momentum A $20M Series A alongside ongoing revenue in the low tens of millions signals a scalable manufacturing and clinical development trajectory, presenting opportunities for CROs, contract manufacturing, and pharmacovigilance services.

Global Expansion Asia-Pacific licensing activity and cross-border development indicate readiness for international market entry support, regulatory affairs services, and regional distribution partnerships.

Technology Stack Fit Utilizing WordPress, Shopify, Google Cloud, and analytics tools shows a modern digital footprint; potential for partnerships in digital trial management, patient engagement platforms, and cloud-enabled data services.

Similar companies to ASKGENE PHARMA, INC.

ASKGENE PHARMA, INC. Tech Stack

ASKGENE PHARMA, INC. uses 8 technology products and services including WordPress, Shopify, Google Workspace, and more. Explore ASKGENE PHARMA, INC.'s tech stack below.

Media & News

ASKGENE PHARMA, INC.'s Email Address Formats

ASKGENE PHARMA, INC. uses at least 1 email format:
ASKGENE PHARMA, INC. Email FormatsExamplePercentage
First.Last@ask-gene.comJohn.Doe@ask-gene.com
100%

Frequently Asked Questions

What is ASKGENE PHARMA, INC.'s official website and social media links?

Minus sign iconPlus sign icon
ASKGENE PHARMA, INC.'s official website is ask-gene.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ASKGENE PHARMA, INC. generate?

Minus sign iconPlus sign icon
As of October 2026, ASKGENE PHARMA, INC.'s annual revenue is estimated to be $10M - $25M.

What is ASKGENE PHARMA, INC.'s NAICS code?

Minus sign iconPlus sign icon
ASKGENE PHARMA, INC.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ASKGENE PHARMA, INC. have currently?

Minus sign iconPlus sign icon
As of October 2026, ASKGENE PHARMA, INC. has approximately 9 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. L., Chief Executive Officer: J. L. and Director Of Upstream Process Development: D. H. Explore ASKGENE PHARMA, INC.'s employee directory with LeadIQ.

What industry does ASKGENE PHARMA, INC. belong to?

Minus sign iconPlus sign icon
ASKGENE PHARMA, INC. operates in the Pharmaceutical Manufacturing industry.

What technology does ASKGENE PHARMA, INC. use?

Minus sign iconPlus sign icon
ASKGENE PHARMA, INC.'s tech stack includes WordPress, Shopify, Google Workspace, Font Awesome, Google Cloud, JSON-LD, WP Engine and Google Tag Manager.

What is ASKGENE PHARMA, INC.'s email format?

Minus sign iconPlus sign icon
ASKGENE PHARMA, INC.'s email format typically follows the pattern of First.Last@ask-gene.com. Find more ASKGENE PHARMA, INC. email formats with LeadIQ.

How much funding has ASKGENE PHARMA, INC. raised to date?

Minus sign iconPlus sign icon
As of October 2026, ASKGENE PHARMA, INC. has raised $20M in funding. The last funding round occurred on Jul 19, 2023.

When was ASKGENE PHARMA, INC. founded?

Minus sign iconPlus sign icon
ASKGENE PHARMA, INC. was founded in 2012.
ASKGENE PHARMA, INC. logo

ASKGENE PHARMA, INC.

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

ASKGENE PHARMA, INC. is a pharmaceutical manufacturing company based in Camarillo, California, at 5217 Verdugo Way Unit A, Camarillo, CA 93012. The company has a small workforce, with 2 to 10 employees. Its activities include the development of therapeutic product candidates, such as ASKG915, for which an Investigational New Drug application was submitted to the U.S. FDA. In 2022, ASKGENE PHARMA announced leadership appointments, including a Chief Medical Officer and a Vice President of Preclinical and Clinical Pharmacology. That year the company also entered licensing and development arrangements, notably with AffaMed for ASKG712 in retinal disease and for AM712 rights in Asia and Japan, and it pursued Series A financing.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
2-10

Section iconFunding & Financials

  • $20M

    ASKGENE PHARMA, INC. has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Jul 19, 2023 as a Series A.

  • $10M - $25M

    ASKGENE PHARMA, INC.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.